# InnoMax MedTech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innomax-medtech

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.innomaxmedtech.com
- Latest round: Series A (Aug 6, 2025)
- Investors on record: 1

## About

Established in 2021 and based in Shenzhen, China, InnoMax Med Tech operates as a medical device manufacturer producing Class I to Class III devices for domestic and international markets. The company has developed a product portfolio that includes portable oxygen concentrators and rehabilitation equipment, targeting healthcare providers and hospitals globally. In August, it completed a Series A funding round from Detong Capital.

The company provides medical devices across Class I, II, and III categories, with core offerings including portable oxygen concentrators, respiratory support equipment, optical diagnostic instruments, and smart rehabilitation devices. Its flagship X-PLO2R portable oxygen concentrator is designed for patients with chronic respiratory diseases such as COPD. The company offers end-to-end services covering product design, research and development, manufacturing and after-sales service, supplying solutions to healthcare institutions and hospitals in multiple international markets.

The company generates revenue from the sale of medical devices through direct B2B transactions and partnerships with healthcare institutions. Revenue is derived from bulk orders and customized supply agreements with hospitals and distributors, with pricing structured around contract terms and order volumes. The X-PLO2R portable oxygen concentrator serves as a key revenue driver, supported by ongoing client relationships and repeat orders.

InnoMax Med Tech plans to use the proceeds from its Series A funding in August 2025 to enhance research and development, accelerate the launch of new products and expand its presence in overseas markets.

## Funding rounds

- Series A, Aug 6, 2025 — Detong Capital

## Investors

- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series A